Alvotech

The Alvotech team is thrilled to kick-off the first day of #CPHIMilan at Fiera Milano. Our beautiful booth, B27 in Hall 10, is ready to welcome partners and guests. We look forward three busy days of meetings and networking and of course the Happy Hour on Wednesday, October 9 at 16:00 🥳 #CPHIMilan #HealthAccess #biosimilars #biopharma Adalvo Alvogen Lotus Pharmaceutical Co., Ltd

Congratulations to Philip A. Caramanica, Alvotech's Chief IP Counsel and Deputy General Counsel, who has been recognized as one of the world's leading IP strategists in IAM Patent Strategy 300 - for the second year in a row! The IAM Patent Strategy 300 list "identifies top practitioners who are taking IP portfolio management to the next level. These individuals are leading the way in developing and implementing strategies that maximize the value of IP portfolios". #biosimilars #healthcareaccess

We are heading to NYC for the Morgan Stanley 22nd Global Healthcare Conference this week. Sign up to listen to a webcast of a discussion with our management team on Thursday September 5, at 5:35 pm ET (21:35 GMT) on our investor portal: https://ow.ly/SEei50TcCTX #biosimilars #healthcareaccess #globalhealthcare2024

The European Medicines Agency (EMA) has accepted the Marketing Authorization Application for AVT06. This brings us one step closer to expanding access to affordable treatment options in ophthalmology for patients across Europe. The approval process is expected to conclude in Q3 2025. A big thank you to our partners and the awesome Alvotech team for their hard work in advancing this important biosimilar candidate. Read all about it in our PR and stay tuned for more updates! https://ow.ly/pce050SZozj #biosimilars #healthcareforall ADVANZ PHARMA BIOGARAN

Annually, Alvotech releases an Equality Report. Recently we released our report for 2023. Alvotech’s Equality Policy is based on Icelandic law but has been implemented globally for all our employees. Our Equal Pay Management System certification is issued by the Icelandic Directorate of Equality and we were recently recertified by the British Standards Institute. In 2023 the unexplained gender pay gap had fallen to 0.6% for employees globally from 5.2% in December 2020, and to 0.7% for employees in Iceland. In 2023, 51% of new hires were women and 55% of job progressions or promotions were women. Alvotech’s equality policy and related disclosure is part of a broader corporate sustainability initiative. The report can be viewed on Alvotech’s Corporate Sustainability portal: https://ow.ly/2sst50Sy5MC. #ESG #equalpay #biosimilars #HealthcareAccess

To improve #HealthcareAccess for all - Alvotech makes both #biosimilars and future leaders. We were of course extremely proud to see the names of Hörður Kári Harðarson, Head of Process and Product Development, and Snorri Páll Sigurðsson, Head of Logistics, on the list of rising stars in Icelandic business this week. 👏 Hörður was named on the '40 under 40' list and Snorri on the 'Rising Stars' list, both published biannually by local PR and HR consultancy Góð samskipti. Congratulations on an honor well-deserved! 🥳 #Leadership #RisingStars

Harshika Sarbajna, Alvotech's VP Commercial & Head Global is a co-chair of the 15th Summit on Biosimilars & Innovator Biologics in NYC, June 20-21. This year could be transformative for the biosimilars and biologics market in the U.S., so there is certainly much to talk about. We look forward to an interesting event. #biosimilars #biologics #biosimilars24 American Conference Institute

We are pleased to grow our partnership with ADVANZ PHARMA, signing a new European commercialization agreement for a biosimilar candidate in eye disease. This demonstrates our common vision for the growth of #biosimilars and strong commitment to providing broader #healthcareaccess to high-quality and more affordable #biologics. Press release: https://ow.ly/Np9u50SkMIp

Thank's Dr. Reddy's Laboratories team. We at look forward to working together, providing better access to safe and effective biologics. Combining our resources will ensure that patients globally can be better served. #healthcareaccess #biosimilars

Thanks to all our guests at Alvotech's Iceland Innovation Week 2024 event. If you were not able to attend, here is a video of the presentations. "Alvotech: How was it made?“: 👉https://ow.ly/y64s50RJvOm